Cite
HARVARD Citation
Okajima, F. et al. (2017). Preventive effect of ipragliflozin on nocturnal hypoglycemia in patients with type 2 diabetes treated with basal‐bolus insulin therapy: An open‐label, single‐center, parallel, randomized control study. Journal of diabetes investigation. 8 (3), pp. 341-345. [Online].